Patients’ knowledge and beliefs concerning gout and its treatment: a population based study

BMC Musculoskeletal Disorders

Robert A Yood²  Cassandra Firneno⁴  Nausheen Naz³  Daniel Peterson⁴  Kathleen M Mazor⁴  Leslie R Harrold¹ 

[1] Department of Medicine, University of Massachusetts Medical School, Biotech 4, Suite 315, 377 Plantation Street, Worcester, MA 01605, USA;Reliant Medical Group, Worcester, MA, USA;University of Massachusetts Medical School, Worcester, MA, USA;Fallon Community Health Plan, Worcester, MA, USA

关键词: Physician-patient communication;    Dietary influence;    Gout;    Treatment;    Beliefs;   

Others  :  1145805
DOI  :  10.1186/1471-2474-13-180

 received in 2012-04-23, accepted in 2012-09-18,  发布年份 2012

【 摘 要 】

Background

For patients to effectively manage gout, they need to be aware of the impact of diet, alcohol use, and medications on their condition. We sought to examine patients’ knowledge and beliefs concerning gout and its treatment in order to identify barriers to optimal patient self-management.

Methods

We identified patients (≥18 years of age) cared for in the setting of a multispecialty group practice with documentation of at least one health care encounter associated with a gout diagnosis during the period 2008–2009 (n = 1346). Patients were sent a questionnaire assessing knowledge with regard to gout, beliefs about prescription medications used to treat gout, and trust in the physician. Administrative electronic health records were used to identify prescription drug use and health care utilization.

Results

Two hundred and forty patients returned surveys out of the 500 contacted for participation. Most were male (80%), white (94%), and aged 65 and older (66%). Only 14 (6%) patients were treated by a rheumatologist. Only a minority of patients were aware of common foods known to trigger gout (e.g., seafood [23%], beef [22%], pork [7%], and beer [43%]). Of those receiving a urate-lowering medication, only 12% were aware of the short-term risks of worsening gout with initiation. These deficits were more common in those with active as compared to inactive gout.

Conclusion

Knowledge deficits about dietary triggers and chronic medications were common, but worse in those with active gout. More attention is needed on patient education on gout and self-management training.

【 授权许可】

   
2012 Harrold et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Lawrence RC, Felson DT, Helmick CG, Arnold LM, Choi H, Deyo RA, Gabriel S, Hirsch R, Hochberg MC, Hunder GG, Jordan JM, Katz JN, Kremers HM, Wolfe F: Estimates of the prevalence of arthritis and other rheumatic conditions in the United States Part II. Arthritis Rheum 2008, 58(1):26-35.
• [2]Wallace KL, Riedel AA, Joseph-Ridge N, Wortmann R: Increasing prevalence of gout and hyperuricemia over 10 years among older adults in a managed care population. J Rheumatol 2004, 31(8):1582-1587.
• [3]Choi HK, Atkinson K, Karlson EW, Willett W, Curhan G: Purine-rich foods, dairy and protein intake, and the risk of gout in men. N Engl J Med 2004, 350(11):1093-1103.
• [4]Choi HK, Liu S, Curhan G: Intake of purine-rich foods, protein, and dairy products and relationship to serum levels of uric acid: the Third National Health and Nutrition Examination Survey. Arthritis Rheum 2005, 52(1):283-289.
• [5]Choi HK, Atkinson K, Karlson EW, Willett W, Curhan G: Alcohol intake and risk of incident gout in men: a prospective study. Lancet 2004, 363(9417):1277-1281.
• [6]Zhang Y, Chen C, Choi H, Chaisson C, Hunter D, Niu J, Neogi T: Purine-rich foods intake and recurrent gout attacks. Ann Rheum Dis 2012. epub ahead of print May 30, 2012 as 10.1136/annrheumdis-2011-201215
• [7]Zhang Y, Woods R, Chaisson CE, Neogi T, Niu J, McAlindon TE, Hunter D: Alcohol consumption as a trigger of recurrent gout attacks. Am J Med 2006, 119(9):800 e13-8.
• [8]Schlesinger N, Dalbeth N, Perez-Ruiz F: Gout–what are the treatment options? Expert Opin Pharmacother 2009, 10(8):1319-1328.
• [9]Harrold LR, Mazor KM, Velten S, Ockene IS, Yood RA: Patients and Providers view gout differently: a qualitative study. Chronic Illn 2010, 6(4):263-271.
• [10]Pal B, Foxall M, Dysart T, Carey F, Whittaker M: How is gout managed in primary care? A review of current practice and proposed guidelines. Clin Rheumatol 2000, 19(1):21-25.
• [11]Shulten P, Thomas J, Miller M, Smith M, Ahern M: The role of diet in the management of gout: a comparison of knowledge and attitudes to current evidence. J Hum Nutr Diet 2009, 22(1):3-11.
• [12]Perez-Ruiz F, Liote F: Lowering serum uric acid levels: what is the optimal target for improving clinical outcomes in gout? Arthritis Rheum 2007, 57(7):1324-1328.
• [13]Harrold LR, Andrade SE: Medication adherence of patients with selected rheumatic conditions: a systematic review of the literature. Semin Arthritis Rheum 2009, 38(5):396-402.
• [14]Riedel AA, Nelson M, Joseph-Ridge N, Wallace K, MacDonald P, Becker M: Compliance with allopurinol therapy among managed care enrollees with gout: a retrospective analysis of administrative claims. J Rheumatol 2004, 31(8):1575-1581.
• [15]Sarawate CA, Brewer KK, Yang W, Patel PA, Schumacher HR, Saag KG, Bakst AW: Gout medication treatment patterns and adherence to standards of care from a managed care perspective. Mayo Clin Proc 2006, 81(7):925-934.
• [16]Solomon DH, Avorn J, Levin R, Brookhart MA: Uric acid lowering therapy: prescribing patterns in a large cohort of older adults. Ann Rheum Dis 2008, 67(5):609-613.
• [17]Harrold LR, Andrade SE, Briesacher BA, Raebel MA, Fouayzi H, Yood RA, Ockene IS: Adherence with urate-lowering therapies for the treatment of gout. Arthritis Res Ther 2009, 11(2):R46. BioMed Central Full Text
• [18]Briesacher BA, Andrade SE, Fouayzi H, Chan KA: Comparison of drug adherence rates among patients with seven different medical conditions. Pharmacotherapy 2008, 28(4):437-443.
• [19]Dugan E, Trachtenberg F, Hall MA: Development of abbreviated measures to assess patient trust in a physician, a health insurer, and the medical profession. BMC Health Serv Res 2005, 5:64. BioMed Central Full Text
• [20]American Board of Internal Medicine: Final report on the patient satisfaction questionnaire project. Washington, DC: ABIM; 1989.
• [21]Blalock SJ, Norton LL, Patel RA, Dooley MA: Patient knowledge, beliefs, and behavior concerning the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Rheum 2005, 53(5):732-739.
• [22]Zhang W, Doherty M, Bardin T, Pascual E, Barskova V, Conaghan P, Gerster J, Jacobs J, Leeb B, Liote F, McCarthy G, Netter P, Nuki G, Perez-Ruiz F, Pignone A, Pimentao J, Punzi L, Roddy E, Uhlig T, Zimmermann-Gorska I: EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2006, 65(10):1312-1324.
• [23]Jordan KM, Cameron JS, Snaith M, Zhang W, Doherty M, Seckl J, Hingorani A, Jaques R, Nuki G: British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of gout. Rheumatology (Oxford) 2007, 46(8):1372-1374.
• [24]Yood RA, Mazor KM, Andrade SE, Emani S, Chan W, Kahler KH: Patient decision to initiate therapy for osteoporosis: the influence of knowledge and beliefs. J Gen Intern Med 2008, 23(11):1815-1821.
• [25]Kim KK, Horan ML, Gendler P, Patel MK: Development and evaluation of the Osteoporosis Health Belief Scale. Res Nurs Health 1991, 14(2):155-163.
• [26]Choi HK: A prescription for lifestyle change in patients with hyperuricemia and gout. Curr Opin Rheumatol 2010, 22(2):165-172.
• [27]Harrold LR, Andrade SE, Briesacher B, Raebel MA, Fouayzi H, Yood RA, Ockene IS: The dynamics of chronic gout treatment: medication gaps and return to therapy. Am J Med 2010, 123(1):54-59.
• [28]Roddy E, Zhang W, Doherty M: Concordance of the management of chronic gout in a UK primary-care population with the EULAR gout recommendations. Ann Rheum Dis 2007, 66(10):1311-1315.
• [29]Safeer RS, Keenan J: Health literacy: the gap between physicians and patients. Am Fam Physician 2005, 72(3):463-468.